Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial

Summary

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Jurjan Aman, Erik Duijvelaar, Liza Botros, Azar Kianzad, Job R Schippers, Patrick J Smeele, Sara Azhang, Imke H Bartelink, Ahmed A Bayoumy, Pierre M Bet, Wim Boersma, Peter I Bonta, Karin A T Boomars, Lieuwe D J Bos, Job J M H van Bragt, Gert-Jan Braunstahl, Lucas R Celant, Katrien A B Eger, J J Miranda Geelhoed, Yurika L E van Glabbeek, Hans P Grotjohan, Laura A Hagens, Chris M Happe, Boaz D Haze

Journal title: The Lancet Respiratory Medicine

Journal publisher: Elsevier Limited

Published year: 2021

DOI identifier: 10.1016/s2213-2600(21)00237-x

ISSN: 2213-2600